US Patent Issued to ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY on Sept. 9 for "Salt form and crystal form of tetrahydrocyclohepta indazole compound" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,155, issued on Sept. 9, was assigned to ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY Co. LTD. (Zhejiang, China).

"Salt form and crystal form of tetrahydrocyclohepta indazole compound" was invented by Ke An (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A class of salt forms and crystal forms of a tetrahydrocyclohepta indazole compound and a preparation method therefor. Specifically disclosed is the uses of the salt form and crystal form of the compound of formula (I) in the preparation of a drug for treating related diseases."

The patent was filed on Dec. 28, 2022, under Application No. 18/723,881.

*For further i...